Jones Financial Companies’s Integra LifeSciences IART Stock Holding History

Jones Financial Companies’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.46K	Sell	159 -2,886	-95%	-$31.7K	﹤0.01%	4243
2025 Q4	$37.8K	Sell	3,045 -134	-4%	-$1.78K	﹤0.01%	2658
2025 Q3	$42K	Sell	3,179 -262	-8%	-$3.59K	﹤0.01%	2455
2025 Q2	$42.3K	Buy	3,441 +137	+4%	+$1.99K	﹤0.01%	2285
2025 Q1	$71.7K	Sell	3,304 -41	-1%	-$964	﹤0.01%	1916
2024 Q4	$75.9K	Buy	3,345 +32	+1%	+$698	﹤0.01%	1725
2024 Q3	$59.2K	Buy	+3,313	New	+$76.8K	﹤0.01%	1579
2021 Q2	–	Sell	-24	Closed	-$2K	–	709
2021 Q1	$2K	Buy	+24	New	+$1.63K	﹤0.01%	736

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Jones Financial Companies's IART Position: Q1 2026 in Review

Jones Financial Companies reduced its Integra LifeSciences (IART) stake by 95% in Q1 2026, selling an estimated $31.7K and leaving 159 shares worth $1.46K. The position accounts for ﹤0.01% of the portfolio, ranked #4243.

Jones Financial Companies first reported a position in IART in Q1 2021 and has held it in 8 quarters since. The position peaked at $75.9K in Q4 2024. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

Jones Financial Companies held 159 shares of Integra LifeSciences worth $1.46K as of Q1 2026.
Jones Financial Companies sold 2,886 Integra LifeSciences shares in Q1 2026, an estimated $31.7K.
Integra LifeSciences made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4243 holding.
Jones Financial Companies first reported a position in Integra LifeSciences in Q1 2021 and has held it in 8 quarters since.
Jones Financial Companies's Integra LifeSciences position peaked at $75.9K in Q4 2024.
201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.